Rocket Lab shares fall 46% as Raymond James starts coverage with $80 target

Verifying
  • Raymond James analyst Brian Gesuale initiated Buy coverage of Rocket Lab with an $80 price target.
  • Rocket Lab shares declined 46% over three months before rising 1.6% to $62.95 Friday.
  • Rocket Lab reported a $2.36 billion backlog, up 137% year over year, at quarter-end.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.